Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precision medicine. It also offers pharmaceutical; hazardous chemical; food additive; medical protective equipment; medical device; manufacturing of basic chemical raw materials; import and export of goods and technology; technical services; and technology development, consulting, exchange, transfer, and promotion. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to Boai NKY Medical Holdings Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Jiaozuo, China.
Frequently asked questions
What sector does Boai NKY Pharmaceuticals Ltd (300109) operate in?
Boai NKY Pharmaceuticals Ltd belongs to the Materials sector and operates in the Specialty Chemicals industry.
What is Boai NKY Pharmaceuticals Ltd (300109) current stock price?
As of the latest data, Boai NKY Pharmaceuticals Ltd stock price is CN¥13.58, with a previous close of CN¥13.58.
What is Boai NKY Pharmaceuticals Ltd (300109) current market capitalization?
Boai NKY Pharmaceuticals Ltd market cap is approximately 7.83 billion.
What is Boai NKY Pharmaceuticals Ltd (300109) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.29.
What is Boai NKY Pharmaceuticals Ltd (300109) Price-to-Earnings (P/E) ratio?
Boai NKY Pharmaceuticals Ltd current P/E ratio is 46.83.
Does Boai NKY Pharmaceuticals Ltd (300109) pay dividends?
Yes. Boai NKY Pharmaceuticals Ltd pays annual dividends with an annualized yield of 1.47% and an estimated annual payout of CN¥0.20 per share.
When is the next ex-dividend date for Boai NKY Pharmaceuticals Ltd (300109)?
The next ex-dividend date is scheduled for June 23, 2027.
What is Boai NKY Pharmaceuticals Ltd (300109) beta (volatility) score?
Boai NKY Pharmaceuticals Ltd has a beta of 0.137, indicating lower volatility than the overall market.
